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The awarding of the 2015 Nobel Prize to Chinese scientist 
YouYou Tu created quite a stir in the media and scientific 
community. This award is the first Nobel Prize in natural 
sciences to a domestic Chinese scientist, and came at a time 
when the whole country was asking: who and when will the 
first domestic Chinese scientist receive this honor? Alt-
hough long anticipated and well deserved, this event cer-
tainly arrived earlier than many expected.  
The World Health Organization classifies malaria as one 
of the three major infectious diseases worldwide. Each year 
it affects no less than one hundred million people and kills 
more than half a million of them, mostly children. Malaria 
used to be rampant in a large part of southern China in the 
not too distant past. The arrival of the quinine class of drugs 
(such as chloroquine), initially found in the bark of Cin-
chona trees, a plant grown in South America, helped treat 
and eradicate this dreadful disease in most regions of China 
as well as some other parts of the world (such as the south-
ern Europe). However, resistance started to develop against 
quinine and other antimalarial drugs. During the latter part 
of the Vietnam War, in late 1960s to early 1970s, malarial 
infections resulted in huge losses of military personnel on 
both sides of the conflict even with the help of some of then 
commonly used antimalarial drugs. Against this backdrop, 
the discovery of artemisinin (Qinghaosu) was the result of 
coordinated efforts of a large team of Chinese scientists 
organized by Chinese government in late 1960s to early 
1970s, in response to a request by the North Vietnamese to 
develop a new and more effective antimalarial drug. A key 
finding was made when Tu’s group improved the extraction 
method and revealed that the wormwood plant, Artemesia 
annua, contains a highly effective compound that can com-
pletely inhibit malarial parasites. This key information im-
mediately shifted the research focus of many other groups, 
resulting in the later collaborative isolation and identifica-
tion of artemisinin [12]. Subsequently, a set of artemisinin 
derivatives (the first generation artemisinin drugs) with 
some better pharmacological properties, including dihy-
droartemisinin, artemether, artesunate and arteether, were 
produced (Figure 1).   
Despite the recent media frenzy surrounding artemisinin, 
few realize that there are more unknown than known about 
this life saving chemical. One of the most critical questions 
is how this miracle drug works. Unfortunately after so many 
years, little is known regarding how it inhibits malarial 
growth. Different theories come and go, and the focus of 
attention has been shifting every 510 years or so, leaving 
this issue very controversial and in a state of confusion 
[3,4]. After the initial efforts of modifying artemisinin, 
mostly made by Chinese scientists, later generations of 
drugs based on artemisinin may have very different back-
bones (Figure 1). These artemisinin derivatives or analogues 
all contain the endoperoxidic bond, the pharmaceutically 
active part of artemisinin drugs. Conventional thinking 
about drug action hypothesizes a target protein, in the ma-
larial parasite inhibited by artemisinins. However, it is real-
ly remarkable and in my opinion even inconceivable how 
these drastically variable molecules, except for their sharing 
of the endoperoxidic bridge, can all be highly potent and 
specific towards a single protein within malaria parasites. 
Drugs usually only work in very specific configurations of 
the atoms, however both the right and left mirror images 
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Figure 1  Structures of artemisinin and some artemisinin-based antimalarial compounds. The endoperoxide bridge, shared by all these compounds, is the 
key pharmacophore. 1, Artemisinin; 2a, dihydroartemisinin(DHA); 2b, artemether; 2c, arteether; 2d, artesunate; 3, An analogue with close structure to arte-
misinin; 4, An antimalarial tetraoxane; 5a, 5b Enantiomers with similar activities against malaria parasites; 6, OZ439 (in clinical trial). 
(enantiomers) of artemisinins appear equally effective. 
There is no doubt that artemisinins represent an amazingly 
unique class of molecules for which we have no prior expe-
rience in understanding at the molecular and cellular level. 
It is no wonder that so far nobody is certain how they work!  
One of the major theories trying to explain the action of 
artemisinins is the heme model. Though details may vary, in 
this model, heme is expected to interact with artemisinin 
and then generate damage in places such as vacuoles in the 
cell. This theory had been a favorite for many years since 
heme can readily react with artemisinins in chemistry, and it 
is natural to link heme to erythrocytes because malaria par-
asites at certain stages indeed accumulate a lot of heme in 
the form of hemozoin, a detoxified and insoluble crystalline 
form of heme. However, no convincing functional data 
support this hypothesis and some data are even not favora-
ble to this model. For example, Ro40-4388, a protease in-
hibitor blocking haemoglobin degradation, displays an an-
tagonistic effect with chloroquine, but no interactions with 
artemisinin. These results suggest that heme interaction is 
not necessary for the antimalarial activity of artemisinin. In 
addition, during the tiny ring and gametocyte stages of the 
malarial parasite, when catabolism of hemoglobin to heme 
does not obviously take place, artemisinins are equally ef-
fective against these stages of the malarial parasites. Anoth-
er similar model proposed that the action of artemisinins is 
mediated by iron in an uncertain form such as free iron, 
heme (heme contains an iron atom) or as Fe-S. Other hy-
potheses include specific protein targets (TCTP, Pfmdr1, 
Pfcrt and PfATP6) for artemisinins. Most recently compel-
ling evidence links the K13-propeller protein of Plasmodi-
um falciparum with “artemisinin resistance” in people [5]. 
Mutations in K13 protein in the parasites enable delayed 
malarial clearance in infected individuals, a phenomenon 
arguably labeled as “artemisinin resistance”. However, par-
asites carrying these mutations are sensitive to the action of 
artemisinins in cell culture studies under constant drug 
pressure [6], suggesting that direct effects on K13 may not 
be a mechanism of the action of artemisinins. One possible 
explanation is that these mutant parasites may be more tol-
erant to stress compared to wild type malaria parasites. In-
deed, a high recrudescence (reoccurrence) rate is often 
linked with short term treatment of malaria with single-drug 
artemisinins, suggesting that the parasite growth is quickly 
suppressed by artemisinins but cell death does not immedi-
ately occur. In this case, it is possible that K13 mutants are 
more resistant to death when dormant, explaining the dif-
ferences between the results in cell culture studies and in 
people with K13 mutant parasites.  
My research group has utilized the yeast, Saccharomyces 
cerevisiae, in combination with direct study of malarial 
parasites and other types of cells such as mammalian cells, 
to study the mechanism of action of artemisinins [7]. The 
yeast model organism serves as a platform to identify the 
possible biological effects of artemisinins which can be 
tested in parasites and mammalian cells. We found that the 
mitochondria of the yeast and subsequently of the malarial 
parasites are highly susceptible to the action of artemisinins. 
When purified mitochondria of the yeast and malarial para-
sites were subject to very low levels of artemisinin (several 
mol L1 or even 100 nmol L1 for parasite mitochondria) 
treatment, almost instant depolarization of the membrane 
occurred, while the mammalian mitochondria could tolerate 
more than 100 mol L1 artemisinins without observable 
effects [8]. We do not know yet what causes these differ-
ences but are actively working to unravel this mystery. Re-
garding the role of heme, we found when reacting with ar-
temisinins, it appears to exert a general damaging effect on 
the cell, much less potent as well as less specific than the 
mitochondrial membrane depolarizing action of artemis-
inins [9]. These two different actions can be utilized to ex-
plain respectively the different properties of artemisinins 
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against malarial parasites and cancer cells: one is very ro-
bust and selective, via membrane depolarization, whereas 
the other one, mediated by heme, is more general and much 
less potent.  
Overall, despite an exciting story, as the media has re-
ported, some of the details of artemisinin discovery are con-
troversial. It is less known that there remain many further 
stories about artemisinins to be told. How do artemisinins, a 
unique class of molecules, achieve their biological effects? 
Are there other applications of artemisinins? Notably, there 
are already indications that artemisinins may find applica-
tions in some other maladies including other infections, 
auto-immune diseases and even cancer [10]. When all the 
gleaming lights and glory about the Nobel Prize settle 
down, we should probably ask ourselves how to address the 
other half of the story, solve the remaining mysteries, and 
take artemisinin research to a new level in our endeavors to 
understand this mesmerizing drug.  
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